Houbaida, Y.; Del Giudice, M. L.; Galimberti, S.; Buda, G. Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS. Mediterr J Hematol Infect Dis 2025, 17, e2025026.